Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3484779010 | Product containing isoniazid and pyrazinamide and rifampicin (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3715373018 | Isoniazid- and pyrazinamide- and rifampicin-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3715374012 | Isoniazid- and pyrazinamide- and rifampin-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Is a | Combined antituberculosis drug | false | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Is a | Isoniazid- and rifampicin-containing product | true | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Is a | Pyrazinamide-containing product | true | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Has active ingredient | Hydrazine | false | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Has active ingredient | Rifampicin | true | Inferred relationship | Some | 2 | |
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Has active ingredient | Pyrazinamide | true | Inferred relationship | Some | 1 | |
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Has active ingredient | Isoniazid | true | Inferred relationship | Some | 3 | |
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Is a | Isoniazid-containing product | false | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Is a | Rifampicin-containing product | false | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Is a | Isoniazid-containing product in oral dose form | false | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Is a | Rifampicin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Isoniazid- and pyrazinamide- and rifampicin-containing product | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Isoniazid and pyrazinamide and rifampicin only product | Is a | True | Isoniazid- and pyrazinamide- and rifampicin-containing product | Inferred relationship | Some | |
| Isoniazid 50 mg and pyrazinamide 300 mg and rifampicin 120 mg oral tablet | Is a | False | Isoniazid- and pyrazinamide- and rifampicin-containing product | Inferred relationship | Some | |
| Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Is a | True | Isoniazid- and pyrazinamide- and rifampicin-containing product | Inferred relationship | Some | |
| Ethambutol- and isoniazid- and pyrazinamide- and rifampicin-containing product | Is a | True | Isoniazid- and pyrazinamide- and rifampicin-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR